Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Cellect reports promising data from phase I/II study of ApoGraft technology

Oct. 16, 2018

TherapyX and Intravacc partner to develop Ngoxim prophylactic vaccine against gonorrhea

Oct. 16, 2018

Astellas Cathespin S inhibitors prolong graft survival in a mouse cardiac transplant model

Oct. 16, 2018

Athenex discloses CRAC modulators as IL-2 production inhibitors

Oct. 11, 2018

New phase II/III trial in Brazil studies meningococcus C vaccine MenCC-Bio

Oct. 11, 2018

Biohaven licenses therapeutic antibody from University of Connecticut

Oct. 10, 2018

Finding improves stem cell safety

Oct. 10, 2018

Glycosylation of allergens increases immune tolerance following immunization

Oct. 10, 2018

VBI-1501 demonstrates safety and immunogenicity in first-in-human study

Oct. 9, 2018

Green Cross initiates phase II study of high-dose quadrivalent influenza vaccine GC-3114

Oct. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...